CellFE
Signal active
Organization
Contact Information
Overview
CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
About
Industries
Biotechnology, Health Care
Founded
2018
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
CellFE headquartered in United States, North America, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $643.2M in funding across 24 round(s). With a team of 11-50 employees, CellFE is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - CellFE, raised $22.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
9
Lead Investors
0
Total Funding Amount
$26.8M
Details
2
CellFE has raised a total of $26.8M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 4.8M | ||
| 2023 | Early Stage Venture | 22.0M |
Investors
CellFE is funded by 23 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| M Ventures | - | FUNDING ROUND - M Ventures | 22.0M |
| Riverine Ventures | - | FUNDING ROUND - Riverine Ventures | 22.0M |
| EGB Capital | - | FUNDING ROUND - EGB Capital | 22.0M |
| CellFE | - | FUNDING ROUND - CellFE | 22.0M |
Recent Activity
There is no recent news or activity for this profile.